Celldex Therapeutics
Develops KIT and bispecific antibodies for mast-cell-driven inflammatory diseases.
$39.12
After-hours close+0.03 (+0.08%)
At close$39.09(−3.39%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$1.02 | — | — |
| Aug 2026 | −$1.06 | −$0.94 | +11.3% |
| May 2026 | −$1.15 | −$1.18 | −2.9% |
| Feb 2026 | −$1.00 | −$1.22 | −22.0% |
| Nov 2025 | −$0.88 | −$1.01 | −14.8% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 9, 2026 | −$1.02 | — | — | $725.8K | — | — |
| Aug 6, 2026 | −$1.06 | −$0.94 | +11.3% | $734.9K | $22.0K | −97.0% |
| May 7, 2026 | −$1.15 | −$1.18 | −2.9% | $795.4K | $15.0K | −98.1% |
| Feb 25, 2026 | −$1.00 | −$1.22 | −22.0% | $1.3M | $100.0K | −92.4% |
| Nov 10, 2025 | −$0.88 | −$1.01 | −14.8% | $1.5M | — | — |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 7, 2025 | ||||||
| May 8, 2025 | ||||||
| Feb 27, 2025 | ||||||
| Nov 6, 2024 | ||||||
| Aug 8, 2024 | ||||||
| May 6, 2024 | ||||||
| Feb 26, 2024 | ||||||
| Nov 2, 2023 | ||||||
| Aug 8, 2023 | ||||||
| May 4, 2023 | ||||||
| Feb 28, 2023 | ||||||
| Nov 9, 2022 | ||||||
| Aug 8, 2022 | ||||||
| May 5, 2022 | ||||||
| Feb 28, 2022 | ||||||
| Nov 9, 2021 | ||||||
| Aug 5, 2021 | ||||||
| May 6, 2021 | ||||||
| Mar 29, 2021 | ||||||
| Nov 5, 2020 | ||||||
| Aug 6, 2020 | ||||||
| May 6, 2020 | ||||||
| Mar 26, 2020 | ||||||
| Nov 12, 2019 | ||||||
| Aug 7, 2019 | ||||||
| May 7, 2019 | ||||||
| Mar 7, 2019 | ||||||
| Nov 7, 2018 | ||||||
| Aug 8, 2018 | ||||||
| May 10, 2018 | ||||||
| Mar 7, 2018 | ||||||
| Nov 7, 2017 | ||||||
| Aug 8, 2017 | ||||||
| May 9, 2017 | ||||||
| Mar 14, 2017 | ||||||
| Nov 7, 2016 | ||||||
| Aug 8, 2016 | ||||||
| May 5, 2016 | ||||||
| Feb 25, 2016 | ||||||
| Nov 5, 2015 | ||||||
| Aug 10, 2015 | ||||||